Press releases

• March 27, 2020 Regulatory press release
  Oasmia Pharmaceutical AB (publ) Interim report for the period May 1, 2019 – January 31, 2020
• March 25, 2020 Regulatory press release
  Oasmia and Elevar sign a global strategic partnership for the commercialization of Apealea® with an upfront payment of USD 20 million, milestone payments with a potential of up to USD 678 million and double digit royalties.
• March 23, 2020
  Oasmia presents Q3 report through audiocast on March 27

All press releases

Financial reports

• Interim Report May 2019 – January 2020
• Interim Report May – October 2019
• Interim Report May – July 2019
• Annual Report 2018 / 2019

All reports

Calendar

• June 18, 2020 Year-end Report May 2019 – April 2020
• August 17 - August 21, 2020 Annual Report 2019 / 2020
• September 9, 2020 14:00 CET Annual General Meeting 2020

All events

The Share

Follow the share